| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 334.00B | 330.83B | 337.26B | 314.34B | 240.81B | 193.75B |
| Gross Profit | 47.14B | 43.24B | 62.40B | 54.16B | 43.87B | 35.42B |
| EBITDA | 29.60B | 31.91B | 32.23B | 30.45B | 26.68B | 19.98B |
| Net Income | 11.41B | 13.07B | 13.23B | 11.74B | 8.51B | 6.83B |
Balance Sheet | ||||||
| Total Assets | 288.73B | 311.48B | 300.98B | 272.55B | 225.76B | 201.94B |
| Cash, Cash Equivalents and Short-Term Investments | 77.25B | 87.66B | 85.78B | 67.04B | 45.97B | 50.09B |
| Total Debt | 56.41B | 75.37B | 57.30B | 42.84B | 49.34B | 42.49B |
| Total Liabilities | 159.65B | 165.15B | 160.64B | 132.99B | 115.38B | 101.05B |
| Stockholders Equity | 125.09B | 141.85B | 135.83B | 134.77B | 106.49B | 97.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -10.98B | 7.87B | 26.29B | 13.84B | 5.57B |
| Operating Cash Flow | 0.00 | 7.20B | 28.22B | 38.63B | 20.27B | 13.54B |
| Investing Cash Flow | 0.00 | -11.57B | -20.13B | -9.66B | -30.04B | -6.96B |
| Financing Cash Flow | 0.00 | 4.13B | 10.95B | -11.43B | 3.98B | -4.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥159.56B | 8.33 | ― | 4.47% | 1.64% | 19.87% | |
75 Outperform | ¥212.54B | 19.50 | 7.50% | 5.39% | -1.82% | 23.07% | |
72 Outperform | ¥141.13B | 16.02 | ― | 2.93% | 3.63% | 35.38% | |
62 Neutral | ¥107.87B | 23.21 | ― | 3.30% | -1.91% | 7.67% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥55.07B | 4.64 | ― | 0.99% | -0.22% | -2.98% | |
55 Neutral | ¥317.30B | 135.95 | ― | 1.93% | <0.01% | -83.75% |